[Pharmacological substances increasing resistance to hypoxia. (Review of the literature)].
D000661:Amphetamine / Q000627:therapeutic use; D000818:Animals; D002110:Caffeine / Q000627:therapeutic use; D002415:Cats; D000697:Central Nervous System Stimulants / Q000627:therapeutic use; D004285:Dogs; D057487:Enzyme Therapy; D004809:Ephedrine / Q000627:therapeutic use; D006168:Guinea Pigs; D006728:Hormones / Q000627:therapeutic use; D006801:Humans; D006873:Hydroquinones / Q000627:therapeutic use; D000860:Hypoxia / Q000517:prevention & control*; D008751:Methylene Blue / Q000627:therapeutic use; D051379:Mice; D009294:Narcotics / Q000627:therapeutic use; D010830:Physostigmine / Q000627:therapeutic use; D011343:Procaine / Q000627:therapeutic use; D011817:Rabbits; D051381:Rats; D013449:Sulfonamides / Q000627:therapeutic use; D014149:Tranquilizing Agents / Q000627:therapeutic use; D014815:Vitamins / Q000627:therapeutic use
D000697:Central Nervous System Stimulants; D006728:Hormones; D006873:Hydroquinones; D009294:Narcotics; D013449:Sulfonamides; D014149:Tranquilizing Agents; D014815:Vitamins; D002110:Caffeine; D011343:Procaine; D010830:Physostigmine; D000661:Amphetamine; D004809:Ephedrine; D008751:Methylene Blue
Farmakologicheskie sredstva, povyshaiushchie ustoĭchivost k gipoksii (obzor literatury)